Lambracht-Washington, D., Qu, B., Fu, M., Anderson, L. D., Stüve, O., Eagar, T. N., & Rosenberg, R. N. (2011). DNA Immunization Against Amyloid beta 42 has High Potential as Safe Therapy for Alzheimer’s Disease as it Diminishes Antigen-Specific Th1 and Th17 Cell Proliferation.
Citação norma ChicagoLambracht-Washington, Doris, Bao-Xi Qu, Min Fu, Larry D. Anderson, Olaf Stüve, Todd N. Eagar, and Roger N. Rosenberg. DNA Immunization Against Amyloid Beta 42 Has High Potential As Safe Therapy for Alzheimer’s Disease As It Diminishes Antigen-Specific Th1 and Th17 Cell Proliferation. 2011.
MLA citiranjeLambracht-Washington, Doris, et al. DNA Immunization Against Amyloid Beta 42 Has High Potential As Safe Therapy for Alzheimer’s Disease As It Diminishes Antigen-Specific Th1 and Th17 Cell Proliferation. 2011.